Addressing multiple neurodivergent identities in clinical and research settings
Addressing multiple neurodivergent identities in clinical and research settings
Neurodiversity is a concept that embraces the different ways that the human brain processes information, functions, and presents behaviourally.1 Instead of thinking in terms of a medical disability that requires treatment, neurodiversity allows the reframing of different brain–behaviour patterns as a form of diversity. Among neurodivergent identities, attention-deficit hyperactivity disorder (ADHD) has a pooled worldwide estimated prevalence of up to 7%, followed by autism at 3–4%.2 Neurodivergent identities are rarely singular, for example 37–85% of autistic children also have ADHD symptoms.3 Despite such high co-occurrence, and the consequential need to reframe the understanding of neurodevelopmental differences as likely to be plural, clinical awareness of them as co-occurring conditions is less established. Part of the lack of awareness comes from the evolution in diagnostic and clinical guidelines, which has happened only in the past 10 years, regarding the identification and therapeutic support of, for example, ADHD and autism as potentially simultaneous conditions.4 Co-occurrence of autism and ADHD was not formally recognised until the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published in 2013. This previous lack of recognition of the possibility of multiple neurodivergence led to uncertainty among health-care practitioners when working with autistic and ADHD children, adolescents, and adults.4 Consequently, screening for multiple neurodivergent conditions is not yet standard clinical practice worldwide. This lack of screening results in late for developmental age diagnoses for simultaneously occurring conditions, such as autism and ADHD; single diagnoses overshadowing a second condition, despite the presentation of multiple neurodivergent conditions; and delayed psychiatric referral, as there is little clinical consensus on how to and who should identify and support multiple-neurodivergent people.
5-6
Chellappa, Sarah
516582b5-3cba-4644-86c9-14c91a4510f2
9 January 2025
Chellappa, Sarah
516582b5-3cba-4644-86c9-14c91a4510f2
Chellappa, Sarah
(2025)
Addressing multiple neurodivergent identities in clinical and research settings.
The Lancet Child & Adolescent Health, 9 (1), .
(doi:10.1016/s2352-4642(24)00261-x).
Abstract
Neurodiversity is a concept that embraces the different ways that the human brain processes information, functions, and presents behaviourally.1 Instead of thinking in terms of a medical disability that requires treatment, neurodiversity allows the reframing of different brain–behaviour patterns as a form of diversity. Among neurodivergent identities, attention-deficit hyperactivity disorder (ADHD) has a pooled worldwide estimated prevalence of up to 7%, followed by autism at 3–4%.2 Neurodivergent identities are rarely singular, for example 37–85% of autistic children also have ADHD symptoms.3 Despite such high co-occurrence, and the consequential need to reframe the understanding of neurodevelopmental differences as likely to be plural, clinical awareness of them as co-occurring conditions is less established. Part of the lack of awareness comes from the evolution in diagnostic and clinical guidelines, which has happened only in the past 10 years, regarding the identification and therapeutic support of, for example, ADHD and autism as potentially simultaneous conditions.4 Co-occurrence of autism and ADHD was not formally recognised until the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), published in 2013. This previous lack of recognition of the possibility of multiple neurodivergence led to uncertainty among health-care practitioners when working with autistic and ADHD children, adolescents, and adults.4 Consequently, screening for multiple neurodivergent conditions is not yet standard clinical practice worldwide. This lack of screening results in late for developmental age diagnoses for simultaneously occurring conditions, such as autism and ADHD; single diagnoses overshadowing a second condition, despite the presentation of multiple neurodivergent conditions; and delayed psychiatric referral, as there is little clinical consensus on how to and who should identify and support multiple-neurodivergent people.
This record has no associated files available for download.
More information
e-pub ahead of print date: 18 November 2024
Published date: 9 January 2025
Identifiers
Local EPrints ID: 502832
URI: https://eprints.soton.ac.uk/id/eprint/502832
ISSN: 2352-4650
PURE UUID: 2b03d758-854f-4356-99bc-e9738ec54efa
Catalogue record
Date deposited: 09 Jul 2025 16:32
Last modified: 03 Oct 2026 02:40
Export record
Altmetrics
Contributors
Author:
Sarah Chellappa
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics